Frank joined Caristo in 2023. He was previously based in Los Angeles as President and CCO of Eyenuk, a diagnostic company with autonomous AI technology that was FDA-cleared, Medicare-reimbursed, supported by a new Category 1 CPT code, and adopted around the world. Earlier in his career Frank held executive positions with publicly traded companies (GE, Roche, Hillrom, Stereotaxis) and led two venture-backed companies as CEO.
10:00am: Greatest health gains – The CVD innovation opportunity